Pacer Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,876,466
| Closed | -$72.4M | – | 3735 |
|
|
2024
Q4 | $72.4M | Buy |
1,876,466
+142,376
| +8% | +$5.5M | 0.16% | 150 |
|
|
2024
Q3 | $78M | Buy |
1,734,090
+1,733,662
| +405,061% | +$78M | 0.16% | 149 |
|
|
2024
Q2 | $14.8K | Sell |
428
-685
| -62% | -$23.7K | ﹤0.01% | 3464 |
|
|
2024
Q1 | $32.2K | Buy |
+1,113
| New | +$32.2K | ﹤0.01% | 3339 |
|
|
2021
Q2 | – | Sell |
-1,780
| Closed | -$46K | – | 1519 |
|
|
2021
Q1 | $46K | Sell |
1,780
-178
| -9% | -$4.6K | ﹤0.01% | 1448 |
|
|
2020
Q4 | $39K | Buy |
+1,958
| New | +$39K | ﹤0.01% | 1438 |
|